PL354111A1 - Combined therapy for treating the both depression and anxiety - Google Patents

Combined therapy for treating the both depression and anxiety

Info

Publication number
PL354111A1
PL354111A1 PL02354111A PL35411102A PL354111A1 PL 354111 A1 PL354111 A1 PL 354111A1 PL 02354111 A PL02354111 A PL 02354111A PL 35411102 A PL35411102 A PL 35411102A PL 354111 A1 PL354111 A1 PL 354111A1
Authority
PL
Poland
Prior art keywords
anxiety
depression
treating
combined therapy
therapy
Prior art date
Application number
PL02354111A
Other languages
English (en)
Inventor
Harry Ralph Howard Jr
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PL354111A1 publication Critical patent/PL354111A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02354111A 2001-05-23 2002-05-23 Combined therapy for treating the both depression and anxiety PL354111A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29306301P 2001-05-23 2001-05-23

Publications (1)

Publication Number Publication Date
PL354111A1 true PL354111A1 (en) 2002-12-02

Family

ID=23127491

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02354111A PL354111A1 (en) 2001-05-23 2002-05-23 Combined therapy for treating the both depression and anxiety

Country Status (10)

Country Link
EP (1) EP1260221A3 (cg-RX-API-DMAC10.html)
JP (1) JP2002370976A (cg-RX-API-DMAC10.html)
KR (1) KR20020090152A (cg-RX-API-DMAC10.html)
CN (1) CN1386504A (cg-RX-API-DMAC10.html)
AU (1) AU4068102A (cg-RX-API-DMAC10.html)
CA (1) CA2386287A1 (cg-RX-API-DMAC10.html)
HU (1) HUP0201720A2 (cg-RX-API-DMAC10.html)
IL (1) IL149705A0 (cg-RX-API-DMAC10.html)
PL (1) PL354111A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200204018B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0514675A (pt) * 2004-09-10 2008-06-17 Pfizer Prod Inc ligantes de éter difenìlico terapêuticos
WO2012004743A1 (en) 2010-07-09 2012-01-12 Pfizer Limited Benzenesulfonamides useful as sodium channel inhibitors
US8609162B2 (en) * 2012-10-04 2013-12-17 Invivo Beverages Llc Integrated neuromodulation system for mood enhancement of a living human subject
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN118116616A (zh) * 2024-01-17 2024-05-31 北京大学第六医院 用于预测帕罗西汀或其药用盐对抑郁或焦虑症患者治疗产生不良反应及指导用药的装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA923283B (en) * 1991-05-29 1993-01-27 Akzo Nv Phenoxyphenyl derivatives
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
ES2139750T3 (es) * 1993-08-06 2000-02-16 Upjohn Co 2-aminoindanos como ligandos selectivos d3 de la dopamina.
WO1996023760A1 (en) * 1995-02-01 1996-08-08 Pharmacia & Upjohn Company 2-aminoindans as selective dopamine d3 ligands
FR2742149B1 (fr) * 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques
YU56301A (sh) * 1999-02-23 2004-05-12 Pfizer Products Inc. Inhibitori resorpcije monoamina za tretiranje poremećaja cns

Also Published As

Publication number Publication date
CN1386504A (zh) 2002-12-25
EP1260221A2 (en) 2002-11-27
IL149705A0 (en) 2002-11-10
CA2386287A1 (en) 2002-11-23
AU4068102A (en) 2002-12-05
JP2002370976A (ja) 2002-12-24
HUP0201720A2 (hu) 2003-07-28
HU0201720D0 (cg-RX-API-DMAC10.html) 2002-07-29
ZA200204018B (en) 2003-11-21
EP1260221A3 (en) 2002-12-18
KR20020090152A (ko) 2002-11-30

Similar Documents

Publication Publication Date Title
GB0111872D0 (en) Therapeutic agents and methods
EP1463438A4 (en) ENDOMURAL THERAPY
EP1423120A4 (en) 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
GB0126879D0 (en) Combination therapy
PL354110A1 (en) Combined therapy for treating the both alcoholism and alcohol dependence
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
GB0119025D0 (en) Compounds and their therapeutic use
GB0101933D0 (en) Therapy
GB0108485D0 (en) Combination therapy
GB0115780D0 (en) Therapeutic molecules and uses thereof
AU5565401A (en) Materials and methods for the treatment of depression
EP1450831A4 (en) PROCESS FOR TREATMENT IN SITU IN THE LUNGS OF MAMMALS
IL149705A0 (en) Combination treatment for depression and anxiety
IL151493A0 (en) Use of dermaciclane for the treatment of anxiety and depression
HU0200253D0 (en) Combination therapy
GB0119803D0 (en) Therapeutic agents
GB2376943B (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use
GB0128122D0 (en) Therapeutic use
IL166025A0 (en) Combination therapy and means for carrying out said therapy
AU2003298547A8 (en) 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety
GB0128512D0 (en) Compounds and their therapeutic use
GB0130736D0 (en) Compounds and their therapeutic use
GB0108821D0 (en) Therapy
GB0108816D0 (en) Therapy

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)